ResMed Inc (RMD)vsTotalEnergies SE ADR (TTE)
RMD
ResMed Inc
$213.81
+0.89%
HEALTHCARE · Cap: $30.87B
TTE
TotalEnergies SE ADR
$92.71
+0.51%
ENERGY · Cap: $205.37B
Smart Verdict
WallStSmart Research — data-driven comparison
TotalEnergies SE ADR generates 3278% more annual revenue ($182.34B vs $5.40B). RMD leads profitability with a 27.5% profit margin vs 7.2%. TTE appears more attractively valued with a PEG of 0.77. RMD earns a higher WallStSmart Score of 70/100 (B).
RMD
Strong Buy70
out of 100
Grade: B
TTE
Buy55
out of 100
Grade: C-
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-16.3%
Fair Value
$223.24
Current Price
$213.81
$9.43 premium
Intrinsic value data unavailable for TTE.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Strong operational efficiency at 35.2%
Safe zone — low bankruptcy risk
Every $100 of equity generates 26 in profit
Keeps 28 of every $100 in revenue as profit
Mega-cap, among the largest globally
Growing faster than its price suggests
Attractively priced relative to earnings
Reasonable price relative to book value
Generating 6.5B in free cash flow
Areas to Watch
No major concerns identified
7.2% margin — thin
Revenue declined 2.5%
Earnings declined 27.4%
Comparative Analysis Report
WallStSmart ResearchBull Case : RMD
The strongest argument for RMD centers on Operating Margin, Altman Z-Score, Return on Equity. Profitability is solid with margins at 27.5% and operating margin at 35.2%. Revenue growth of 11.0% demonstrates continued momentum.
Bull Case : TTE
The strongest argument for TTE centers on Market Cap, PEG Ratio, P/E Ratio. PEG of 0.77 suggests the stock is reasonably priced for its growth.
Bear Case : RMD
No major red flags identified for RMD, but monitor valuation.
Bear Case : TTE
The primary concerns for TTE are Profit Margin, Revenue Growth, EPS Growth.
Key Dynamics to Monitor
RMD profiles as a mature stock while TTE is a value play — different risk/reward profiles.
RMD carries more volatility with a beta of 0.93 — expect wider price swings.
RMD is growing revenue faster at 11.0% — sustainability is the question.
TTE generates stronger free cash flow (6.5B), providing more financial flexibility.
Bottom Line
RMD scores higher overall (70/100 vs 55/100), backed by strong 27.5% margins and 11.0% revenue growth. Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
ResMed Inc
HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA
ResMed is a San Diego, California-based medical equipment company. It primarily provides cloud-connectable medical devices for the treatment of sleep apnea (such as CPAP devices and masks), chronic obstructive pulmonary disease (COPD), and other respiratory conditions.
Visit Website →TotalEnergies SE ADR
ENERGY · OIL & GAS INTEGRATED · USA
TotalEnergies SE is a global integrated oil and gas company. The company is headquartered in Paris, France.
Compare with Other MEDICAL INSTRUMENTS & SUPPLIES Stocks
Want to dig deeper into these stocks?